Grupo Collins

Grupo Collins, established in 1967, is a Mexican pharmaceutical company with over 55 years of market experience. It specializes in manufacturing and commercializing safe, effective, generic, and branded medications at fair prices. Committed to Mexican families' health, Grupo Collins operates four production plants meeting high global quality standards. Its portfolio includes over 140 products across 14 therapeutic lines, serving diverse healthcare needs.

The company's operations are centered at a single primary location. Grupo Collins employs 1,000-5,000 professionals dedicated to its mission. Their product range features numerous over-the-counter (OTC) medications for accessible treatment of common ailments. This focus on accessible healthcare is driven by their expert team. Meet Grupo Collins's team to learn about the professionals behind their operations. The company reports revenue of $699.3M, indicating significant market engagement.

Grupo Collins actively pursues social responsibility and community health education. By providing quality pharmaceuticals at fair prices, it ensures broader access to essential medicines. Its strategic focus on diverse therapeutic needs and ethical practices solidifies its role in the Mexican healthcare sector. The company maintains its online presence at www.collins.mx, facilitating information access and engagement.